Trulieve exec Hersey reports 85,173 share holding
Trulieve Cannabis Corp. executive Christine Ann Hersey, Chief Corporate Affairs & Strategy, has filed an initial statement of beneficial ownership.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Trulieve Cannabis Corp. executive Christine Ann Hersey, Chief Corporate Affairs & Strategy, has filed an initial statement of beneficial ownership. She directly holds 85,173 subordinate voting shares, which include several grants of restricted stock units that vest over multiple years.
Hersey also holds multiple stock options giving her the right to buy Trulieve subordinate voting shares at exercise prices ranging from $3.99 to $47.23, with expiration dates between 2029 and 2032. These options generally vest in annual installments, with portions already exercisable and the remainder scheduled to vest through December 2027.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Hersey Christine Ann
Role
Chief Corp Affairs & Strategy
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Subordinate Voting Shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 170,977 contracts (Direct);
Subordinate Voting Shares — 85,173 shares (Direct)
Footnotes (9)
- F1. The amount of securities beneficially owned in column 2 includes several grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The reporting person: (i) was granted 8,380 RSUs on February 24, 2022, subject to 2-year vesting; the RSUs vested 50% on each of December 1, 2023 and December 1, 2024; (ii) was granted 24,156 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs vested 50% on each of December 1, 2024 and December 1, 2025; (iii) was granted 15,750 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs vested 50% on December 1, 2025 and will vest 50% on December 1, 2026; and (iv) was granted 43,424 RSUs on March 25, 2025, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2026 and 50% on December 1, 2027.
- F2. These options were originally granted under the Harvest Health & Recreation Inc. 2018 Stock and Incentive Plan and, in connection with Trulieve's acquisition of Harvest Health & Recreation Inc. on October 1, 2021, were converted into options to purchase Trulieve subordinate voting shares at an adjusted exercise price.
- F3. The options were granted on September 10, 2019, and vest 25% per year in equal installments, starting on the grant date. One fourth of the options vested and became exercisable on each of September 10, 2019, September 10, 2020, September 10, 2021 and September 10, 2022.
- F4. The options were granted February 3, 2020, and vest 25% per year in equal installments, starting on September 10, 2019. One fourth of the options vested and became exercisable on each of September 10, 2019, September 10, 2020, September 10, 2021 and September 10, 2022.
- F5. The options were granted on December 31, 2020, and vest 50% per year in equal installments, starting on the grant date. One half of the options vested and became exercisable on each of December 31, 2020 and December 31, 2021.
- F6. The options were granted on February 24, 2022, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2022, December 1, 2023 and December 1, 2024.
- F7. The options were granted on July 25, 2023, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2023, December 1, 2024 and December 1, 2025.
- F8. The options were granted on March 8, 2024, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2024 and December 1, 2025, and one third of the options will vest and become exercisable on December 1, 2026.
- F9. The options were granted on March 25, 2025, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2025, one third of the options will vest and become exercisable on December 1, 2026, and one third of the options will vest and become exercisable on December 1, 2027.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Trulieve Cannabis Corp. (TCNNF) Form 3 for Christine Ann Hersey show?
The Form 3 shows that executive Christine Ann Hersey beneficially owns 85,173 subordinate voting shares of Trulieve Cannabis Corp. It also details several stock option grants and restricted stock units that vest over time, providing potential additional share ownership if fully exercised and vested.
What stock options are reported for Christine Ann Hersey in the Trulieve (TCNNF) Form 3?
Hersey holds several stock options to buy Trulieve subordinate voting shares, with individual grants covering 2,925, 1,097, 4,387, 7,955, 53,754, 28,519, and 72,340 shares. Exercise prices range from $3.99 to $47.23, expiring between 2029 and 2032.
How do Christine Ann Hersey’s RSUs vest according to the Trulieve (TCNNF) Form 3?
The filing explains that Hersey received several RSU grants that generally vest over two years. Specific grants from 2022, 2023, 2024, and 2025 vest in 50% or one-third installments on December 1 dates from 2023 through 2027, creating a staggered vesting schedule.
Are Christine Ann Hersey’s Trulieve (TCNNF) stock options fully vested?
No, the stock options follow various vesting schedules. Many earlier grants have fully vested, while later grants vest in annual installments. Some portions vest on December 1 dates through 2026 and 2027, meaning a portion remains unvested and becomes exercisable over time.
What is the significance of Trulieve’s acquisition of Harvest Health & Recreation in this Form 3?
The filing notes that certain options were originally granted under the Harvest Health & Recreation Inc. 2018 Stock and Incentive Plan. After Trulieve’s acquisition of Harvest on October 1, 2021, these options were converted into options to purchase Trulieve subordinate voting shares at adjusted exercise prices.
AI-generated analysis. How Rhea-AI works. Not financial advice.
